GlobeNewsWire
02 Oct 2025, 20:43 UTC · 49w ago
Verdict
Headline takes no side. We score XOMA +0.30 — moderately bullish.
+0.30moderately bullish
More positive than 58% of ticker scores this week
Which stocks this story touches
More positive than 58% of ticker scores this week
The company is actively expanding its portfolio through the acquisition of LAVA Therapeutics.
More positive than 52% of ticker scores this week
The company is being acquired via a tender offer, providing shareholders with cash and contingent value rights.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 96% of relationship scores this week
[a_to_b] XOMA Royalty Corporation has launched a tender offer to acquire all outstanding shares of LAVA Therapeutics.
More positive than 56% of relationship scores this week
[mutual] LAVA is partnered with Johnson & Johnson on the JNJ-89853413 asset.
More positive than 56% of relationship scores this week
[mutual] LAVA is partnered with Pfizer on the PF-08046052 asset.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Reuters
2h ago
+1.6%
Price agrees with the score
$40.17 vs $39.54 close before publication (Oct 2) · not market-adjusted
XOMA chart →
